Investment Intelligence provides up-to-date private equity information and news designed for entrepreneurs, private equity investors and corporate acquirors interested in Central & Eastern Europe.

PDC Biotech

PDC Biotech Series A Closes With €4 Million

Austrian pharmaceutical company PDC Biotech GmbH (PDC) recently announced the close of Series A financing, topping the €4 million mark. Co-leading the round were France's Edmond de Rothschild Investment Partners and Germany's MIG Verwaltungs AG. Combined with earlier seed funding of €1 million and a grant of €517,000, PDC's total funding is now more than €5.56 million. The recent investments will be used to continue development of PDC's inaugural product which it hopes to have in Phase I testing by next year.